TRAF6 and cancer: Seventy-four unique Reactome terms were selected in IStoI comparison, including “MAP2K and MAPK activation”, “TRAF6-mediated IRF7 activation”, “CTLA4-inhibitory signaling”, “signaling by Hippo” and “signaling by WNT in cancer”.